Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways

This publication has 62 references indexed in Scilit:

• Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer
  Nature Communications, 2018
• Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis
  Oncogene, 2017
• Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy
  Seminars in Cancer Biology, 2016
• Wnt5a Signals through DVL1 to Repress Ribosomal DNA Transcription by RNA Polymerase I
  PLOS Genetics, 2016
• Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
  Cell Stem Cell, 2015
• Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer
  Biochemical Pharmacology, 2014
• Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
  Proceedings of the National Academy of Sciences, 2014
• Antioxidant Activities of Hydroxytyrosol Main Metabolites Do Not Contribute to Beneficial Health Effects after Olive Oil Ingestion
  Drug Metabolism and Disposition, 2010
• LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
  Proceedings of the National Academy of Sciences, 2010
• The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
  Cell, 2008